Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Cancer Treatment Reports|July 1, 1981
Pharmacokinetics of leucovorin rescue using a new methotrexate-independent biochemical assay for leucovorin and N5-methyltetrahydrofolateE Hamel, G Johnson, D GlaubigerCancer Research|May 1, 1984
Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cellsA Ramu, L Cohen, D GlaubigerCancer Research|October 1, 1984
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analoguesA Ramu, D Glaubiger, Z FuksCancer Treatment Reports|April 1, 1984
Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cellsA Ramu, D Glaubiger, H WeintraubInternational Journal of Radiation Oncology, Biology, Physics|April 1, 1985
Actuarial risk of isolated CNS involvement in Ewing's sarcoma following prophylactic cranial irradiation and intrathecal methotrexateM E Trigg, R Makuch, D GlaubigerCancer Treatment Reports|October 1, 1983
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cellsA Ramu, T C Shan, D GlaubigerRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1986
Conservative treatment of breast cancer in Europe: report of the Groupe Européen de CuriethérapieB Pierquin, J J Mazeron, D GlaubigerBiochimica Et Biophysica Acta|March 28, 1979
Qualitative and quantitative aspects of intercalator-induced DNA strand breaksW E Ross, D Glaubiger, K W KohnCancer Research|January 1, 1984
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleateA Ramu, Z Fuks, S Gatt, et al.Cancer Research|November 1, 1983
Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cellsA Ramu, D Glaubiger, I T Magrath, et al.Pageof 3